Katakura Industries Co., Ltd.

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: JP3211400001
JPY
2,978.00
-9 (-0.3%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.

Comparison
Company
Score
Quality
Valuation
Financial
Technical
Towa Pharmaceutical Co., Ltd.
Mochida Pharmaceutical Co., Ltd.
Earth Corp.
Zeria Pharmaceutical Co., Ltd.
Katakura Industries Co., Ltd.
JCR Pharmaceuticals Co., Ltd.
KYORIN Pharmaceutical Co., Ltd.
Torii Pharmaceutical Co., Ltd.
SAWAI GROUP HOLDINGS Co., Ltd.
Kaken Pharmaceutical Co., Ltd.
Nxera Pharma Co., Ltd.
Why is Katakura Industries Co., Ltd. ?
1
Company's ability to service its debt is strong with a healthy EBIT to Interest (avg) ratio of 29.19
2
Poor long term growth as Net Sales has grown by an annual rate of -1.36% over the last 5 years
3
Flat results in Jun 25
  • RAW MATERIAL COST(Y) Grown by 6.82% (YoY)
  • INTEREST(Q) Highest at JPY 34 MM
4
With ROE of 5.22%, it has a very attractive valuation with a 0.92 Price to Book Value
  • The stock is trading at a premium compared to its peers' average historical valuations
  • Over the past year, while the stock has generated a return of 51.36%, its profits have risen by 9.5% ; the PEG ratio of the company is 1.9
  • At the current price, the company has a high dividend yield of 0
5
Market Beating Performance
  • The stock has generated a return of 51.36% in the last 1 year, much higher than market (Japan Nikkei 225) returns of 29.35%
stock-recommendationReal-Time Research Report
Verdict Report
How much should you hold?
  1. Overall Portfolio exposure to Katakura Industries Co., Ltd. should be less than 10%
  2. Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock

Is Katakura Industries Co., Ltd. for you?

Low Risk, High Return

Absolute
Risk Adjusted
Volatility
Katakura Industries Co., Ltd.
53.27%
843.63
30.67%
Japan Nikkei 225
28.54%
1.14
25.81%
stock-recommendationQuality
stock-summaryManagement Risk
stock-summaryGrowth
stock-summaryCapital Structure
stock-recommendation
Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors
Factor
Value
Sales Growth (5y)
-1.36%
EBIT Growth (5y)
12.92%
EBIT to Interest (avg)
29.19
Debt to EBITDA (avg)
0
Net Debt to Equity (avg)
-0.24
Sales to Capital Employed (avg)
0.44
Tax Ratio
49.16%
Dividend Payout Ratio
46.43%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
6.23%
ROE (avg)
5.85%
stock-recommendationValuation
Valuation Scorecard stock-summary
stock-recommendation
Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors stock-summary
Factor
Value
P/E Ratio
18
Industry P/E
Price to Book Value
0.92
EV to EBIT
11.83
EV to EBITDA
7.47
EV to Capital Employed
0.89
EV to Sales
1.43
PEG Ratio
1.85
Dividend Yield
0.02%
ROCE (Latest)
7.51%
ROE (Latest)
5.22%
stock-recommendationTechnicals
Technical key factors
Indicator
Weekly
Monthly
MACD
Bullish
Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bullish
Mildly Bullish
Moving Averages
Bullish (Daily)
KST
Mildly Bearish
Bullish
Dow Theory
No Trend
No Trend
OBV
No Trend
No Trend
stock-recommendation Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
Technical Movement
stock-recommendationFinancial Trend
Financial Trend Scorecard stock-summary
stock-recommendation
Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

13What is working for the Company
ROCE(HY)

Highest at 6.42%

DEBT-EQUITY RATIO (HY)

Lowest at -25.61 %

DEBTORS TURNOVER RATIO(HY)

Highest at 3.26%

OPERATING PROFIT MARGIN(Q)

Highest at 22.34 %

NET PROFIT(Q)

Highest at JPY 2,191 MM

EPS(Q)

Highest at JPY 68.49

-10What is not working for the Company
RAW MATERIAL COST(Y)

Grown by 6.82% (YoY

INTEREST(Q)

Highest at JPY 34 MM

Here's what is working for Katakura Industries Co., Ltd.
Operating Profit Margin
Highest at 22.34 %
in the last five periods
MOJO Watch
Company's profit margin has improved

Operating Profit to Sales

Net Profit
Highest at JPY 2,191 MM
in the last five periods
MOJO Watch
Near term Net Profit trend is positive

Net Profit (JPY MM)

Net Profit
At JPY 2,191 MM has Grown at 107.08%
over average net sales of the previous four periods of JPY 1,058.05 MM
MOJO Watch
Near term Net Profit trend is positive

Net Profit (JPY MM)

EPS
Highest at JPY 68.49
in the last five periods
MOJO Watch
Increasing profitability; company has created higher earnings for shareholders

EPS (JPY)

Debt-Equity Ratio
Lowest at -25.61 %
in the last five Semi-Annual periods
MOJO Watch
The company has been reducing its borrowing as compared to equity capital

Debt-Equity Ratio

Debtors Turnover Ratio
Highest at 3.26%
in the last five Semi-Annual periods
MOJO Watch
Company has been able to sell its Debtors faster

Debtors Turnover Ratio

Here's what is not working for Katakura Industries Co., Ltd.
Interest
Highest at JPY 34 MM
in the last five periods and Increased by 6.25% (QoQ)
MOJO Watch
Rising interest cost signifies increased borrowings

Interest Paid (JPY MM)

Raw Material Cost
Grown by 6.82% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has deteriorated; this may lead to a fall in profit margin

Raw Material Cost as a percentage of Sales